GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genexine Inc (XKRX:095700) » Definitions » Other Stockholders Equity

Genexine (XKRX:095700) Other Stockholders Equity : ₩-29,509 Mil (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Genexine Other Stockholders Equity?

Genexine's Other Stockholders Equity for the quarter that ended in Mar. 2024 was ₩-29,509 Mil.

Genexine's quarterly Other Stockholders Equity increased from Sep. 2023 (₩-54,358 Mil) to Dec. 2023 (₩-32,537 Mil) and increased from Dec. 2023 (₩-32,537 Mil) to Mar. 2024 (₩-29,509 Mil).

Genexine's annual Other Stockholders Equity declined from Dec. 2021 (₩106,779 Mil) to Dec. 2022 (₩-69,975 Mil) but then increased from Dec. 2022 (₩-69,975 Mil) to Dec. 2023 (₩-32,537 Mil).


Genexine Other Stockholders Equity Historical Data

The historical data trend for Genexine's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genexine Other Stockholders Equity Chart

Genexine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,354.12 126,088.34 106,778.94 -69,975.44 -32,537.25

Genexine Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -61,803.42 -49,062.38 -54,357.76 -32,537.25 -29,508.78

Genexine Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Genexine Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Genexine's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Genexine (XKRX:095700) Business Description

Traded in Other Exchanges
N/A
Address
700 Daewangpangyo-ro, Gyeonggi-do, Korea Bio Park Building B, Bundang-gu, Seongnam-si, KOR, 13488
Genexine Inc is a clinical-stage biotechnology company. It is focused on the development and commercialization of immunotherapeutics and next-generation long-acting biologics. Its primary technologies are Therapeutic DNA vaccine technology and Hyfc platform. The company's product pipeline includes products such as GX-H9, GX-E2, GX-G3, GX-G6, and Papitrol-188 among others.

Genexine (XKRX:095700) Headlines

No Headlines